| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11008766 | Annals of Vascular Surgery | 2018 | 18 Pages |
Abstract
The role of cellular therapy with PBMNCs is decisive in the patients that are not susceptible to revascularization. In diabetic patients with CLI and healing resistant ulcers, the adjuvant PBMNCs therapy could represent a valid therapeutic option.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Francesca Persiani, Alessandra Paolini, Daniele Camilli, Luca Mascellari, Alessandro Platone, Alessandra Magenta, Sergio Furgiuele,